Interestingly, C-Myc is a gene directly targeted by the Notch2 signaling pathway.77 Therefore, upregulation of C-Myc by Kir2.1-activated Notch2 signaling might contribute to the malignant phenotype of non-WNT/SHH MBs. This evidence concerns the gene NOTCH2 and Mobius syndrome.